Actively Recruiting
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Led by UCB Biopharma SRL · Updated on 2026-05-01
20
Participants Needed
12
Research Sites
77 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
CONDITIONS
Official Title
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be at least 18 years old at the time of signing the consent
- Currently treated with commercial bimekizumab according to your doctor's prescription
- Breastfeeding and planning to breastfeed throughout the sampling period
- Have been on bimekizumab treatment for at least 12 weeks after delivery before sampling starts
- Not pregnant and do not plan to become pregnant during the study
- Treatment and breastfeeding decisions made independently before consenting to the study
You will not qualify if you...
- Have any medical, obstetrical, or psychiatric condition that could affect your ability to participate, as judged by the investigator
- Infant has any abnormalities that may affect participation, as judged by the investigator
- History of chronic alcohol or drug abuse in the past year
- History of breast implants, augmentation, or reduction surgery
- Planning or expecting surgery during screening or sampling periods (except tubal ligation)
- Participated in another investigational drug or device study in the last 6 months or currently participating, except certain allowed studies
- Previously participated in this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
Up0122 105
Santa Monica, California, United States, 90404
Actively Recruiting
2
Up0122 103
South Miami, Florida, United States, 33155
Actively Recruiting
3
Up0122 102
Durham, North Carolina, United States, 27710
Actively Recruiting
4
Up0122 101
Milwaukee, Wisconsin, United States, 53226
Actively Recruiting
5
Up0122 202
Calgary, Canada
Actively Recruiting
6
Up0122 201
Vancouver, Canada
Actively Recruiting
7
Up0122 301
Freiburg im Breisgau, Germany
Actively Recruiting
8
Up0122 303
Herne, Germany
Actively Recruiting
9
Up0122 501
Barcelona, Spain
Actively Recruiting
10
Up0122 502
Barcelona, Spain
Actively Recruiting
11
Up0122 602
Lausanne, Switzerland
Actively Recruiting
12
Up0122 601
Sankt Gallen, Switzerland
Actively Recruiting
Research Team
U
UCB Cares
CONTACT
U
UCB Cares
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here